Drug intelligence / Profile preview

lonicerae japonicae caulis

Development stage: Unknown
Administration: Oral, Topical

Overview

Lonicerae Japonicae Caulis is the aboveground stem part of Lonicera japonica Thunb., a plant classified as a medicine-food homology species in China. It is traditionally used for clearing heat, detoxifying, dredging wind, and unblocking collaterals. Modern research indicates it contains various active metabolites such as organic acids, volatile oils, flavonoids, triterpenes, and triterpene saponins. Its pharmacological effects include anti-inflammatory, antibacterial, antitumor (anticancer), antioxidant activities, and the ability to repair bone and soft tissue[1]. The drug has significant research and clinical application value but is not widely recognized as a pharmaceutical outside traditional medicine systems[1][3].

Brand names: Ren Dong Teng Granules
Other names: Lonicera Japonica Stem

Beyond the preview

Go deeper on lonicerae japonicae caulis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on lonicerae japonicae caulis.

Explore the full profile